{"transactions":[{"id":1857206,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":112387,"kind":"person","name":"Johnson Wendy S.","position":1,"cik":"0001652822","reported_name":"Johnson Wendy S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option(right to buy)","published_at":"2023-06-13T16:35:40.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date."}],"balance_after":9000,"derivative":{"exercise_price":3.13,"expiration_date":"2033-06-08","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001274737-23-000060","document":"wf-form4_168668852605535.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652822/000127473723000060/wf-form4_168668852605535.xml","form_type":"4"}},{"id":2225430,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":112387,"kind":"person","name":"Johnson Wendy S.","position":1,"cik":"0001652822","reported_name":"Johnson Wendy S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option(right to buy)","published_at":"2022-06-21T08:34:01.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date."}],"balance_after":9000,"derivative":{"exercise_price":5.25,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001274737-22-000046","document":"wf-form4_165581482752855.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652822/000127473722000046/wf-form4_165581482752855.xml","form_type":"4"}},{"id":2577236,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":112387,"kind":"person","name":"Johnson Wendy S.","position":1,"cik":"0001652822","reported_name":"Johnson Wendy S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-07T08:25:27.000Z","date":"2021-09-03","kind":"purchase","acquired":true,"shares":1000,"price":14.02,"value":14020.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001274737-21-000101","document":"wf-form4_163101751499196.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652822/000127473721000101/wf-form4_163101751499196.xml","form_type":"4"}},{"id":2633178,"issuer":{"id":6550,"kind":"organization","name":"OnKure Therapeutics, Inc.","symbol":"OKUR"},"owners":[{"id":112387,"kind":"person","name":"Johnson Wendy S.","position":1,"cik":"0001652822","reported_name":"Johnson Wendy S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2021-07-15T17:33:47.000Z","date":"2021-07-14","kind":"sale","acquired":false,"shares":111736,"price":8.5,"value":949756.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person previously notified the Issuer of her intention to retire from her position as the Issuer's Chief Development Officer, effective on or before December 31, 2021. Following her announcement, the Reporting Person exercised an option totaling 111,736 shares of Common Stock of the Issuer (the \"Shares\") on July 8, 2021. The Reporting Person is selling the Shares privately to Abingworth Bioventures 8 LP (\"Abingworth\"), an existing stockholder of the Issuer.  Bali Muralidhar, a Director of the Issuer, is a member of the investment committee of Abingworth."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-046802","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652822/000120919121046802/doc4.xml","form_type":"4"}},{"id":2637035,"issuer":{"id":6550,"kind":"organization","name":"OnKure Therapeutics, Inc.","symbol":"OKUR"},"owners":[{"id":112387,"kind":"person","name":"Johnson Wendy S.","position":1,"cik":"0001652822","reported_name":"Johnson Wendy S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock option (right to buy)","published_at":"2021-07-09T18:52:11.000Z","date":"2021-07-08","kind":"exercise","acquired":false,"shares":111736,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.97,"exercise_date":"2017-09-01","expiration_date":"2028-04-04","underlying":"Common Stock","underlying_shares":111736},"source":{"system":"sec-edgar","filing":"0001209191-21-046254","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652822/000120919121046254/doc4.xml","form_type":"4"}},{"id":2637034,"issuer":{"id":6550,"kind":"organization","name":"OnKure Therapeutics, Inc.","symbol":"OKUR"},"owners":[{"id":112387,"kind":"person","name":"Johnson Wendy S.","position":1,"cik":"0001652822","reported_name":"Johnson Wendy S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2021-07-09T18:52:11.000Z","date":"2021-07-08","kind":"exercise","acquired":true,"shares":111736,"price":1.97,"value":220119.92,"ownership":{"direct":true},"balance_after":111736,"source":{"system":"sec-edgar","filing":"0001209191-21-046254","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652822/000120919121046254/doc4.xml","form_type":"4"}},{"id":2660995,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":112387,"kind":"person","name":"Johnson Wendy S.","position":1,"cik":"0001652822","reported_name":"Johnson Wendy S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option(right to buy)","published_at":"2021-06-21T08:38:34.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date."}],"balance_after":9000,"derivative":{"exercise_price":16.41,"expiration_date":"2031-06-16","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001274737-21-000074","document":"wf-form4_162427910066558.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652822/000127473721000074/wf-form4_162427910066558.xml","form_type":"4"}},{"id":3018584,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":112387,"kind":"person","name":"Johnson Wendy S.","position":1,"cik":"0001652822","reported_name":"Johnson Wendy S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option(right to buy)","published_at":"2020-10-01T16:33:27.000Z","date":"2020-10-01","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is exercisable as it vests. The total number of shares of common stock subject to the option vests in 36 equal monthly installments over the three-year period beginning on November 1, 2020, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":11.25,"expiration_date":"2030-09-30","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001274737-20-000088","document":"wf-form4_160158439447223.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652822/000127473720000088/wf-form4_160158439447223.xml","form_type":"4"}},{"id":4213039,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":112387,"kind":"person","name":"Johnson Wendy S.","position":1,"cik":"0001652822","reported_name":"Johnson Wendy S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-09-12T00:21:22.000Z","date":"2017-09-07","kind":"grant","acquired":true,"shares":10900,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10900,"derivative":{"exercise_price":0.91,"exercise_date":"2018-09-07","expiration_date":"2027-09-06","underlying":"Common Stock","underlying_shares":10900},"source":{"system":"sec-edgar","filing":"0001209191-17-052312","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000120919117052312/doc4.xml","form_type":"4"}}]}